According to the business intelligence report titled ‘GLOBAL Antithrombotic Drugs Market 2019-2027’, available with Market Study Report, global antithrombotic drugs market is projected to record a y-o-y growth rate of 6.61% between 2019-2027.
 

Growing geriatric population, coupled with rising occurrence of chronic and genetic diseases are leading factors boosting global antithrombotic drugs market expansion. Moreover, changing lifestyles, growing cases of hypertension, and rising awareness among patients about potentially deadly diseases are fostering the demand for antithrombotic drugs.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2486984/
 

While lapse of licenses, in consort with high cost and shortage of NOACs (novel oral anticoagulants) will inhibit global antithrombotic drugs market growth, growing healthcare businesses, and rising pervasiveness of coagulation diseases are likely to stimulate the industry outlook.
 

The report examines the marketplace at a granular level by dividing it based on region, end user gamut, and application scope. Details about industry share held by each segment and individual growth rate predictions over 2019-2027 are given in the research document.
 

Based on types, worldwide antithrombotic drugs industry is bifurcated into anticoagulants, antiplatelets (oral and IV), and thrombin inhibitors (direct factor XA inhibitors, direct thrombin inhibitors, and thrombolytic agents).
 

From the regional frame of reference, Asia Pacific antithrombotic drugs market size is projected to expand rapidly between 2019-2027, owing to high awareness, development of healthcare infrastructure, and growing patient pool across the region.
 

Key players profiled in the global antithrombotic drugs market report are Baxter International Inc., Armetheon Inc., The Merck Group, Sanofi S.A., GlaxoSmithKline plc, Novartis International AG, Bayer AG, Abbott Laboratories, CSL Behring LLC, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Eli Lilly & Company, Daiichi Sankyo Company Limited, F. Hoffmann-La Roche AG, and C.H. Boehringer Sohn AG & Co. KG.
 

These companies have made strategic decisions like product launches, investments, alliances, partnerships and mergers & acquisitions which has helped them hold a significant market share and maximize profits.